ArticleFrontiers in oncology2026
Small-cell neuroendocrine carcinoma of the descending colon in a young adult: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors arising from neuroendocrine cells with malignant potential. NENs of the colorectum are uncommon, and colonic neuroendocrine neoplasms (CNENs) are particularly rare. Here, we report the diagnostic and therapeutic course of a man in his 25-year-old with small-cell neuroendocrine carcinoma (SCNEC) of the descending colon. The patient presented with sudden, severe abdominal pain accompanied by nausea and vomiting. Computed tomography (CT) revealed circumferential wall thickening of the descending colon, blurring of the surrounding fat planes, and multiple small regional lymph nodes; contrast-enhanced CT demonstrated marked, homogeneous, and persistent enhancement. The initial imaging findings were easily confounded with inflammatory disease, and the patient declined further evaluation and was discharged. Nine months later, he was readmitted because of progressive intestinal obstruction. Imaging showed substantial progression of the lesion with extension to the sigmoid colon, accompanied by signs of extra-serosal invasion and peritoneal dissemination. Colonoscopy and histopathology confirmed SCNEC. The patient received ascites control, etoposide plus carboplatin chemotherapy, and supportive care, but the response was poor. This combination of young age and tumor location in the descending colon appears to be uncommon in the existing literature. The case is further distinguished by the presence of circumferential colonic wall thickening on imaging, a feature absent in prior reports. This case highlights that colonic SCNEC in young patients may present with atypical imaging features. Colonic NENs should be included in the differential diagnosis, and early endoscopic biopsy should be performed; definitive diagnosis relies on histopathology and immunohistochemistry to facilitate early recognition and standardized management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.